EGFR MUTATION
Clinical trials for EGFR MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR MUTATION trials appear
Sign up with your email to follow new studies for EGFR MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to outsmart lung cancer resistance
Disease control Not yet recruitingThis study tests a new drug (ANS014004) combined with a standard targeted therapy (EGFR-TKI) in people with advanced lung cancer that has a specific gene change (EGFR mutation). The goal is to find a safe dose and see if the combination can shrink tumors or stop them from growing…
Matched conditions: EGFR MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New combo targets lung cancer brain metastases in 60-patient trial
Disease control Not yet recruitingThis study tests whether a higher dose of furmonertinib alone works better than a standard dose combined with chemotherapy for people with a specific type of lung cancer (EGFR-mutated) that has spread to the brain. About 60 adults who have not had treatment before will take part.…
Matched conditions: EGFR MUTATION
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 06:49 UTC